Please assess the completion status of the following clinical trial:

Trial Title: Mometasone vs Budesonide in CRS With Polyposis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of chronic rhinosinusitis with nasal polyps~* Absence of active infection at start of study~Exclusion Criteria:~* Diagnosis of chronic rhinosinusitis without nasal polyps~* Diagnosis of recurrent acute bacterial rhinosinusitis~* Previous sinus surgery (septal of inferior turbinate surgeries are not considered sinus surgeries)~* Cystic fibrosis or ciliary dyskinesia~* Allergy to corticosteroids~* Pregnant or lactating women~* Contra-indication to intranasal steroids

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Mometasone nasal spray (Type: ACTIVE_COMPARATOR): Mometasone nasal spray 50 mcg/dose, 2 sprays/nostril twice daily x 3 months Patients will also be taking Sinus Rinse once daily throughout the study period
- Budesonide irrigation (Type: EXPERIMENTAL): 2 cc budesonide nebule (0,5 mg/cc) incorporated to 240 of saline water (Sinus Rinse) to be taken on a daily basis x 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).